Free Newsletter
Biomarkers offer little help to cardiologists
New biomarkers being tracked for cardiac risk did help provide indicators of a person's condition, according to Harvard researchers. But the biomarkers currently offer little more than what physicians can already glean from a patients record for smoking, obesity, blood pressure and cholesterol levels. Article
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
